Regulatory requirements for outsourcing sterilization activity of medical devices by a manufacturer under Medical Device Rules, 2017
Immediate withdrawal of the permission to manufacture all combinations of Tapentadol and all combinations of Caresoprodol
Gastro Resistant Tablets or Capsules, Delayed Release Tablets or Capsules as New Drugs as per Rule 2, (1)(w) of the New Drugs and Clinical Trials Rules, 2019
Evaluation of certain pre 1988 permitted Fixed Dose Combinations (FDCs) de novo for manufacture for sale in the country wiithout due approval from Central Licensing Authority
FDC cleared by DCGI from 1961 to feb 2013
FDC cleared by DCGI from 1961 to feb 2013 (CIRCULARS) Read More »
Grant of Blood centre licence through ONDLS portal
Grant of Blood centre licence through ONDLS portal (CIRCULARS) Read More »
Validity of FSSAI recognised Food Testing Laboratories
Validity of FSSAI recognised Food Testing Laboratories (CIRCULARS) Read More »
Enforcement of Plastic Waste Management Rules
Enforcement of Plastic Waste Management Rules (CIRCULARS) Read More »
Prohibition of issuance of ASU drug licence for commercialisation of human breast milk
Ulipristal Tablets 5 mg RESTRICTED USE
Ulipristal Tablets 5 mg RESTRICTED USE PDF File (CIRCULARS) Read More »
